Skip to main content
OpenTrials

Clinical trial condition

Metastatic Digestive System Neuroendocrine Neoplasm

Explore clinical trials studying Metastatic Digestive System Neuroendocrine Neoplasm. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Metastatic Digestive System Neuroendocrine Neoplasm trial results

Active, Not Recruiting

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

NCT03375320

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
Locations
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 433 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors

NCT04234568

Conditions
Metastatic Digestive System Neuroendocrine Neoplasm, Metastatic Neuroendocrine Tumor, Neoplasms, +5 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions